-
1
-
-
0020057397
-
Ketoconazole: A review of its therapeutic efficacy in superficial and systemic fungal infections
-
1:CAS:528:DyaL38XhtlGjt7Y%3D 10.2165/00003495-198223010-00001
-
Heel RC, Brogden RN, Carmine A, Morley PA, Speight TM, Avery GS. Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections. Drugs. 1982;23:1-36.
-
(1982)
Drugs
, vol.23
, pp. 1-36
-
-
Heel, R.C.1
Brogden, R.N.2
Carmine, A.3
Morley, P.A.4
Speight, T.M.5
Avery, G.S.6
-
2
-
-
0018921956
-
The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole
-
1:CAS:528:DyaL3cXhslGjtLY%3D 10.1093/jac/6.1.97
-
Odds FC, Milne LJR, Gentles JC, Ball EH. The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole. J Antimicrob Chemother. 1980;6:97-104.
-
(1980)
J Antimicrob Chemother
, vol.6
, pp. 97-104
-
-
Odds, F.C.1
Milne, L.J.R.2
Gentles, J.C.3
Ball, E.H.4
-
3
-
-
0030633665
-
Use of azoles for systemic antifungal therapy
-
Kauffman A, Carver P. Use of azoles for systemic antifungal therapy. Adv Pharmacol. 1997;39:147-89.
-
(1997)
Adv Pharmacol
, vol.39
, pp. 147-189
-
-
Kauffman, A.1
Carver, P.2
-
4
-
-
84900671951
-
-
US Patent 3,717,655. 23 July
-
Godefroi EF, Herees J. Inventors, Janssen Pharmaceutica, Assignee. Antifungal and antibacterial compositions of certain imidazols and methods of using same. US Patent 3,717,655. 23 July 1969.
-
(1969)
Inventors, Janssen Pharmaceutica, Assignee. Antifungal and Antibacterial Compositions of Certain Imidazols and Methods of Using Same
-
-
Godefroi, E.F.1
Herees, J.2
-
5
-
-
77958531109
-
Improvement of solubility and dissolution properties of ketoconazole by solid dispersions and inclusion complexes
-
Balata G, Mahdi M, Bakera RA. Improvement of solubility and dissolution properties of ketoconazole by solid dispersions and inclusion complexes. Asian J Pharm Sci. 2010;5:1-12.
-
(2010)
Asian J Pharm Sci
, vol.5
, pp. 1-12
-
-
Balata, G.1
Mahdi, M.2
Bakera, R.A.3
-
6
-
-
0033663452
-
Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25
-
10.1016/S0928-0987(00)00173-1
-
Van den Mooter G, Wuyts M, Blaton N, Busson R, Grobet P, Augustijns P, Kinget R. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci. 2001;12:261-9.
-
(2001)
Eur J Pharm Sci
, vol.12
, pp. 261-269
-
-
Van Den Mooter, G.1
Wuyts, M.2
Blaton, N.3
Busson, R.4
Grobet, P.5
Augustijns, P.6
Kinget, R.7
-
7
-
-
0000312699
-
Physicochemical and drug-delivery considerations for oral drug bioavailability
-
1:CAS:528:DyaK2sXjs1Cgtg%3D%3D 10.1016/1359-6446(96)10039-8
-
Chan OH, Stewart BH. Physicochemical and drug-delivery considerations for oral drug bioavailability. Drug Discov Today. 1996;1:461-73.
-
(1996)
Drug Discov Today
, vol.1
, pp. 461-473
-
-
Chan, O.H.1
Stewart, B.H.2
-
8
-
-
57049163132
-
Drug delivery strategies for improved azole antifungal action
-
1:CAS:528:DC%2BD1cXhtlaisrbL 10.1517/17425240802457188
-
Yang W, Wiederhold NP, Williams RO. Drug delivery strategies for improved azole antifungal action. Expert Opin Drug Deliv. 2008;5:1199-216.
-
(2008)
Expert Opin Drug Deliv
, vol.5
, pp. 1199-1216
-
-
Yang, W.1
Wiederhold, N.P.2
Williams, R.O.3
-
9
-
-
0036724743
-
Antifungal drug resistance to azoles and polyenes
-
1:CAS:528:DC%2BD38XnsFOjtbk%3D 10.1016/S1473-3099(02)00371-7
-
Canuto MM, Gutierrez F. Antifungal drug resistance to azoles and polyenes. Lancet Infect Dis. 2002;2:550-63.
-
(2002)
Lancet Infect Dis.
, vol.2
, pp. 550-563
-
-
Canuto, M.M.1
Gutierrez, F.2
-
10
-
-
78449296944
-
Effective formulation development strategies for poorly soluble active pharmaceutical ingredients (APIs)
-
1:CAS:528:DC%2BC3cXhsFyqu7rF
-
Elder DP. Effective formulation development strategies for poorly soluble active pharmaceutical ingredients (APIs). Am Pharm Rev. 2010;13:28-34.
-
(2010)
Am Pharm Rev
, vol.13
, pp. 28-34
-
-
Elder, D.P.1
-
11
-
-
84867825837
-
Solid dispersions: A strategy for poorly aqueous soluble drugs and technology updates
-
1:CAS:528:DC%2BC38XhsFCgsbfN 10.1517/17425247.2012.732064
-
Alam MA, Ali R, Al-Jenoobi FI, Al-Mohizea AM. Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates. Expert Opin Drug Deliv. 2012;9:1419-40.
-
(2012)
Expert Opin Drug Deliv
, vol.9
, pp. 1419-1440
-
-
Alam, M.A.1
Ali, R.2
Al-Jenoobi, F.I.3
Al-Mohizea, A.M.4
-
12
-
-
79959380233
-
Phase diagram and dissolution studies of the fenofibrate-acetylsalicylic acid system
-
10.1007/s10973-010-1148-3
-
Górniak A, Wojakowska A, Karolewicz B, Pluta J. Phase diagram and dissolution studies of the fenofibrate-acetylsalicylic acid system. J Therm Anal Calorim. 2011;104:1195-200.
-
(2011)
J Therm Anal Calorim
, vol.104
, pp. 1195-1200
-
-
Górniak, A.1
Wojakowska, A.2
Karolewicz, B.3
Pluta, J.4
-
13
-
-
84881478244
-
Thermal, spectroscopic, and dissolution studies of the simvastatin-acetylsalicylic acid mixtures
-
10.1007/s10973-012-2641-7
-
Górniak A, Karolewicz B, Zurawska-Płaksej E, Pluta J. Thermal, spectroscopic, and dissolution studies of the simvastatin- acetylsalicylic acid mixtures. J Therm Anal Calorim. 2013;111:2125-32.
-
(2013)
J Therm Anal Calorim
, vol.111
, pp. 2125-2132
-
-
Górniak, A.1
Karolewicz, B.2
Zurawska-Płaksej, E.3
Pluta, J.4
-
14
-
-
79955592721
-
Nanoparticle formation and growth during in vitro dissolution of ketoconazole solid dispersion
-
1:CAS:528:DC%2BC3MXlslCgs74%3D 10.1002/jps.22491
-
Kanaujia P, Lau G, Kiong W, Widjaja E, Hanefeld A, Fischbach M, Maio M, Tan RBH. Nanoparticle formation and growth during in vitro dissolution of ketoconazole solid dispersion. J Pharm Sci. 2011;100:2876-85.
-
(2011)
J Pharm Sci
, vol.100
, pp. 2876-2885
-
-
Kanaujia, P.1
Lau, G.2
Kiong, W.3
Widjaja, E.4
Hanefeld, A.5
Fischbach, M.6
Maio, M.7
Tan, R.B.H.8
-
15
-
-
79955604485
-
Physicochemical characterization and dissolution study of solid dispersions of ketoconazole with nicotinamide
-
1:CAS:528:DC%2BC38XnvFCntA%3D%3D 10.1248/cpb.59.629
-
Aggarwal AK, Jain S. Physicochemical characterization and dissolution study of solid dispersions of ketoconazole with nicotinamide. Chem Pharm Bull. 2011;59:629-38.
-
(2011)
Chem Pharm Bull
, vol.59
, pp. 629-638
-
-
Aggarwal, A.K.1
Jain, S.2
-
16
-
-
84859531522
-
Physicochemical characterization and release rate studies of solid dispersions of ketoconazole with Pluronic F127 and PVP K-30
-
1:CAS:528:DC%2BC38XisFCqtro%3D
-
Kumar P, Mohan Ch, Umashankar MS, Gulati M. Physicochemical characterization and release rate studies of solid dispersions of ketoconazole with Pluronic F127 and PVP K-30. Iran J Pharm Res. 2011;10:685-94.
-
(2011)
Iran J Pharm Res
, vol.10
, pp. 685-694
-
-
Kumar, P.1
Mohan, C.2
Umashankar, M.S.3
Gulati, M.4
-
17
-
-
77954751060
-
Enhancement of dissolution rate of ketoconazole by solid dispersion technique
-
Najmuddin M, Khan T, Mohsin AA, Shelar S, Patel V. Enhancement of dissolution rate of ketoconazole by solid dispersion technique. Int J Pharm Pharm Sci. 2010;3:132-6.
-
(2010)
Int J Pharm Pharm Sci
, vol.3
, pp. 132-136
-
-
Najmuddin, M.1
Khan, T.2
Mohsin, A.A.3
Shelar, S.4
Patel, V.5
-
18
-
-
23844542459
-
Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole
-
1:CAS:528:DC%2BD2MXltVamtbw%3D 10.1007/BF02977766
-
Heo M-Y, Piao Z-Z, Kim T-W, Cao Q-R, Kim A, Lee B-J. Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole. Arch Pharm Res. 2005;28:604-11.
-
(2005)
Arch Pharm Res
, vol.28
, pp. 604-611
-
-
Heo, M.-Y.1
Piao, Z.-Z.2
Kim, T.-W.3
Cao, Q.-R.4
Kim, A.5
Lee, B.-J.6
-
19
-
-
0038759662
-
Amphiphilic block copolymers for drug delivery
-
1:CAS:528:DC%2BD3sXltlWhu7g%3D 10.1002/jps.10397
-
Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery. J Pharm Sci. 2003;92:1343-55.
-
(2003)
J Pharm Sci
, vol.92
, pp. 1343-1355
-
-
Adams, M.L.1
Lavasanifar, A.2
Kwon, G.S.3
-
20
-
-
33845351355
-
A review of poloxamer 407 pharmaceutical and pharmacological characteristics
-
1:CAS:528:DC%2BD28Xht1Kmt73I 10.1007/s11095-006-9104-4
-
Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006;23:2709-28.
-
(2006)
Pharm Res
, vol.23
, pp. 2709-2728
-
-
Dumortier, G.1
Grossiord, J.L.2
Agnely, F.3
Chaumeil, J.C.4
-
21
-
-
79960120015
-
Preparation, physico chemical characterization of solid dispersions of tenoxicam with poloxamer
-
1:CAS:528:DC%2BC3cXhsVWksL7J
-
Saritha A, Nalini Shastri N. Preparation, physico chemical characterization of solid dispersions of tenoxicam with poloxamer. J Pharm Sci Technol. 2010;2:308-11.
-
(2010)
J Pharm Sci Technol
, vol.2
, pp. 308-311
-
-
Saritha, A.1
Nalini Shastri, N.2
-
22
-
-
84875422594
-
Phase diagram of ibuprofen with fatty acids
-
1:CAS:528:DC%2BC3sXksFensrk%3D 10.1007/s10973-012-2831-3
-
Benessam S, Khimeche K, Djellouli F, Benziane M, Dahmani A. Phase diagram of ibuprofen with fatty acids. J Therm Anal Calorim. 2013;112:317-20.
-
(2013)
J Therm Anal Calorim
, vol.112
, pp. 317-320
-
-
Benessam, S.1
Khimeche, K.2
Djellouli, F.3
Benziane, M.4
Dahmani, A.5
-
23
-
-
0037074108
-
The mechanism of drug release from solid dispersion in water-soluble polymers
-
1:CAS:528:DC%2BD3MXptlaitL0%3D 10.1016/S0378-5173(01)00891-2
-
Craig DQ. The mechanism of drug release from solid dispersion in water-soluble polymers. Int J Pharm. 2002;231:131-44.
-
(2002)
Int J Pharm
, vol.231
, pp. 131-144
-
-
Craig, D.Q.1
|